NCT07361744

Brief Summary

hronic obstructive pulmonary disease (COPD) is a common lung disease that can worsen suddenly, leading to hospital admission. During these exacerbations, breathing becomes unstable and recovery is difficult to predict. Currently, doctors lack simple tools to monitor how patients recover day by day during hospitalization and after discharge. This observational study aims to describe how breathing patterns during sleep change over time in patients hospitalized for a COPD exacerbation. Breathing will be monitored using standard sleep recordings and a non-contact sensor placed under the mattress, which measures breathing without disturbing the patient. By better understanding how nocturnal breathing variability evolves during recovery, this study may help identify early signs of improvement or deterioration, support safer hospital discharge decisions, and improve follow-up after hospitalization for COPD exacerbation

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
18mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Dec 2025Nov 2027

Study Start

First participant enrolled

December 9, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 23, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

1.3 years

First QC Date

December 15, 2025

Last Update Submit

January 15, 2026

Conditions

Keywords

sleepbreathing variability

Outcome Measures

Primary Outcomes (1)

  • Nocturnal ventilatory variability during sleep assessed by polysomnography

    Nocturnal ventilatory variability will be quantified during sleep using polysomnography. Variability will be assessed on a breath-by-breath basis using 30-second analysis windows and summarized by the following predefined indice SD. SD will be calculated separately for each sleep stage (N1, N2, N3, REM) and then averaged across total sleep time for each recording night.

    Baseline (first night after hospitalization), Day 3 of hospitalization, Day 7 of hospitalization or the day before discharge (if discharge occurs earlier), and 6 weeks after hospital discharge (study completion)

Secondary Outcomes (5)

  • Nocturnal ventilatory variability assessed by a non-contact respiratory sensor

    Nightly during hospitalization (up to 7 days) and during one overnight recording at 6 weeks after hospital discharge

  • Correlation between nocturnal ventilatory variability and clinical worsening during hospitalization

    From baseline (first night after hospitalization) through Day 7 of hospitalization or the day before discharge (maximum hospitalization duration: 7 days)

  • Correlation between nocturnal ventilatory variability and physician-assessed readiness for hospital discharge

    Daily from baseline (first night after hospitalization) until hospital discharge (up to 7 days)

  • Association between nocturnal ventilatory variability and 28-day hospital readmission

    Up to 28 days after hospital discharge

  • Correlation between nocturnal ventilatory variability and daytime ventilatory drive assessed by parasternal electromyography

    Day 1, Day 3, Day 7 (or the night before discharge if discharge occurs earlier), and 6 weeks after hospital discharge.

Study Arms (1)

COPD acute exacerbations

Consecutive patients admitted in a medicine hospital department for acute exacerbation of COPD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population consists of adult patients with a confirmed diagnosis of chronic obstructive pulmonary disease (COPD) who are hospitalized for an acute exacerbation. Eligible participants are included within the first 24 hours of admission to an acute medical ward and are able to provide informed consent. All participants have COPD diagnosed by spirometry according to standard criteria and are admitted for management of an exacerbation not requiring invasive or non-invasive mechanical ventilation at the time of inclusion. Patients receiving long-term positive airway pressure therapy or home non-invasive ventilation are excluded. The study population reflects a real-life hospitalized COPD cohort, encompassing a range of disease severity, clinical trajectories, and comorbidities commonly observed during acute exacerbations. Participants are followed during hospitalization and up to six weeks after discharge to characterize changes in nocturnal ventilatory patterns during recovery.

You may qualify if:

  • Adults (≥ 18 years) with a confirmed diagnosis of chronic obstructive pulmonary disease (COPD) based on spirometry
  • Admitted to an acute medical ward
  • Able to provide written informed consent
  • Affiliated with the national health insurance system

You may not qualify if:

  • Long-term non-invasive ventilation or positive airway pressure therapy prior to hospitalization
  • Use of an anti-pressure (anti-decubitus) mattress incompatible with the study devices
  • Severe anxiety disorders interfering with study procedures
  • Known allergy to materials used for sensor placement
  • Pregnancy or breastfeeding
  • Minor or legally protected adult (guardianship, curatorship) or deprivation of liberty
  • Lack of health insurance coverage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pitié-Salpétrière Hospital

Paris, 75013, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2025

First Posted

January 23, 2026

Study Start

December 9, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations